Agency Information Collection Activities; Submission to the Office of Management and Budget (OMB) for Review and Approval; Comment Request; COVID-19 Vaccine Supplemental Medical Provider Statement, 16719-16721 [2022-06333]

Download as PDF khammond on DSKJM1Z7X2PROD with NOTICES Federal Register / Vol. 87, No. 57 / Thursday, March 24, 2022 / Notices to 5 p.m., and April 13, 2022, from 10 a.m. to 5 p.m. All meetings will be at Eastern Standard Time. ADDRESSES: Meeting address: The hybrid meeting will be held at the Courtyard Marriott Isla Verde Beach Resort, 7012 Boca de Cangrejos, Carolina, Puerto Rico, 00979. You may join the SSC public hybrid meeting via Zoom by entering the following address: https:// us02web.zoom.us/j/87345855856? pwd=SDc1V1NIK24xcEF0Zlhud0 lTNlcvdz09. Meeting ID: 873 4585 5856. Passcode: 793249. One tap mobile: +19399450244,,87345855856#,,,, *793249# Puerto Rico +17879451488,,87345855856#,,,, *793249# Puerto Rico Dial by your location: +1 939 945 0244 Puerto Rico +1 787 945 1488 Puerto Rico +1 787 966 7727 Puerto Rico +1 312 626 6799 U.S. (Chicago) +1 346 248 7799 U.S. (Houston) +1 646 558 8656 U.S. (New York) +1 669 900 9128 U.S. (San Jose) +1 253 215 8782 U.S. (Tacoma) +1 301 715 8592 U.S. (Washington, DC) Meeting ID: 873 4585 5856. Passcode: 793249. Find your local number: https:// us02web.zoom.us/u/kKUpZ2IPc. In case there are problems and we cannot reconnect via Zoom, the meeting will continue via GoToMeeting. You may join from a computer, tablet or smartphone by entering the following address: https://meet.goto.com/ 474688061. You can also dial in using your phone. United States: +1 (872) 240–3212 Access Code: 474–688–061 Join from a video-conferencing room or system. Dial in or type: 67.217.95.2 or inroomlink.goto.com Meeting ID: 474 688 061 Or dial directly: 474688061@ 67.217.95.2 or 67.217.95.2##474688061. Get the app now and be ready when the first meeting starts: https:// meet.goto.com/install. FOR FURTHER INFORMATION CONTACT: Miguel Rolo´n, Executive Director, Caribbean Fishery Management Council, 270 Mun˜oz Rivera Avenue, Suite 401, San Juan, Puerto Rico 00918–1903, telephone: (787) 398–3717. SUPPLEMENTARY INFORMATION: The following items included in the tentative agenda will be discussed: VerDate Sep<11>2014 17:39 Mar 23, 2022 Jkt 256001 April 12, 2022 10 a.m.–10:15 a.m. —Call to order —Roll call —Approval of Verbatim Transcriptions —Adoption of agenda 10:15 a.m.–12:30 p.m. —Integrative analyses and visualization of SEAMAP-Caribbean (SEAMAP–C) data in Puerto Rico and the U.S. Virgin Islands (aka The Gold Copy)— JJ Cruz Motta —Dashboard/Puerto Rico Port Sampling and Catch Validation Project—Todd Gedamke —Discussion and Recommendations to the CFMC 12:30 p.m.–1:30 p.m. —Lunch 1:30 p.m.–3 p.m. —Southeast Fishery Science Center (SEFSC) Caribbean Branch Update —SEFSC Inventory Update—Kevin McCarthy and Rachel Eckley —SSC Recommendations to CFMC 3 p.m.–3:15 p.m. —Break 3:15 p.m.–5 p.m. —SEDAR-Stock Assessment Matrix— Kevin McCarthy, SEFSC —Life history Update—Virginia Shervette/Noemi Pen˜a/Jesus Rivera —Continue discussion and recommendations to CFMC April 13, 2022 10 a.m.–12 p.m. —Island-Based Fishery Management Plan and Amendments Update— Marı´a Lo´pez-Mercer, SERO/NOAA Fisheries —Updated OFLs/ABCs for spiny lobster for years 2024–2026—SEFSC —Update/SSC Review —National SSC Update—Richard Appeldoorn —SSC Recommendations to CFMC –Lunch 1 p.m.–3 p.m. —Caribbean Fishery Management Council’s (CFMC) 5-year Strategic Plan—Michelle Duval —Discussion: SSC Research Plan Recommendations to CFMC 3 p.m.–3:15 p.m. 3:15 p.m.–5 p.m. —Finalize Research Priorities and Recommendations to CFMC Fmt 4703 Special Accommodations For any additional information on this public virtual meeting, please contact Dr. Graciela Garcı´a-Moliner, Caribbean Fishery Management Council, 270 Mun˜oz Rivera Avenue, Suite 401, San Juan, Puerto Rico 00918–1903, telephone: (787) 403–8337. Authority: 16 U.S.C. 1801 et seq. Dated: March 21, 2022. Tracey L. Thompson, Acting Deputy Director, Office of Sustainable Fisheries, National Marine Fisheries Service. [FR Doc. 2022–06257 Filed 3–23–22; 8:45 am] BILLING CODE 3510–22–P DEPARTMENT OF COMMERCE Agency Information Collection Activities; Submission to the Office of Management and Budget (OMB) for Review and Approval; Comment Request; COVID–19 Vaccine Supplemental Medical Provider Statement United States Patent and Trademark Office, Department of Commerce. ACTION: Notice of information collection; request for comment. AGENCY: —Break Frm 00016 —Ecosystem-Based Fishery Management Technical Advisory Panel (EBFM TAP) Update —Sennai Habtes —SSC Ecosystem Conceptual Model review —Where is it and how is it being used —Lenfest overview (JJ Cruz Motta, Stacey Williams, Tarsila Seara) —Plan to Meld Conceptual Models— Potentially Create Task Force— Orian Tzadik —DAPs ECM overview (Liajay Rivera) —Ecosystem Status Report: Ecosystem Indicators—Kelly Montenero, Mandy Karnauskas, SEFSC —SSC Recommendations to the CFMC —Other Business —Adjourn The order of business may be adjusted as necessary to accommodate the completion of agenda items. The meeting will begin on April 12, 2022, at 10 a.m. EST, and will end on April 13, 2022, at 5 p.m. EST. Other than the start time, interested parties should be aware that discussions may start earlier or later than indicated, at the discretion of the Chair. In addition, the meeting may be completed prior to the date established in this notice. United States Patent and Trademark Office 12 p.m.–1 p.m. PO 00000 16719 Sfmt 4703 E:\FR\FM\24MRN1.SGM 24MRN1 16720 Federal Register / Vol. 87, No. 57 / Thursday, March 24, 2022 / Notices The United States Patent and Trademark Office (USPTO), as required by the Paperwork Reduction Act of 1995, invites comments on the extension and revision of an existing information collection: 0651–0087 (COVID–19 Vaccine Supplemental Medical Provider Statement). The purpose of this notice is to allow 60 days for public comment preceding submission of the information collection to OMB. DATES: To ensure consideration, comments regarding this information collection must be received on or before May 23, 2022. ADDRESSES: Interested persons are invited to submit written comments by any of the following methods. Do not submit Confidential Business Information or otherwise sensitive or protected information. • Email: InformationCollection@ uspto.gov. Include ‘‘0651–0087 comment’’ in the subject line of the message. • Federal Rulemaking Portal: http:// www.regulations.gov. • Mail: Kimberly Hardy, Office of the Chief Administrative Officer, United States Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313– 1450. FOR FURTHER INFORMATION CONTACT: Request for additional information should be directed to Naveen Paul, Office of Equal Employment Opportunity and Diversity, United States Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313– 1450; by telephone at 571–270–5395; or by email at Naveen.Paul@uspto.gov with ‘‘0651–0087 comment’’ in the subject line. Additional information about this information collection is also available at http://www.reginfo.gov under ‘‘Information Collection Review.’’ SUPPLEMENTARY INFORMATION: SUMMARY: I. Abstract khammond on DSKJM1Z7X2PROD with NOTICES Consistent with guidance from the Centers for Disease Control and Prevention (CDC), guidance from the Safer Federal Workforce Task Force established pursuant to E.O. 13991 of January 20, 2021, Protecting the Federal Workforce and Requiring Mask-Wearing, and E.O. 14043 of September 9, 2021, VerDate Sep<11>2014 17:39 Mar 23, 2022 Jkt 256001 Requiring Coronavirus Disease 2019 Vaccination for Federal Employees, the request for this collection of information is essential to implement the USPTO health and safety measures regarding the Federal employee medical exemptions to the COVID–19 mandatory vaccinations. The Rehabilitation Act of 1973, as amended, requires Federal agencies to provide reasonable accommodations to qualified employees with disabilities unless that reasonable accommodation would impose an undue hardship on the employee’s agency. See 29 U.S.C. 791; 29 CFR part 1614; see also 20 CFR part 1630 and E.O.13164 of July 26, 2000, Requiring Federal Agencies to Establish Procedures to Facilitate the Provision of Reasonable Accommodation. Section 2 of E.O. 14043 mandates that each agency ‘‘implement, to the extent consistent with applicable law, a program to require COVID–19 vaccination for all of its Federal employees, with exceptions only as required by law.’’ This COVID–19 Vaccine Supplemental Medical Provider Statement is necessary for USPTO to determine legal exemptions to the vaccine requirement under the Rehabilitation Act. The vaccination requirement issued pursuant to E.O. 14043, is currently the subject of a nationwide injunction. While that injunction remains in place, USPTO will not process requests for a medical exception from the COVID–19 vaccination requirement pursuant to E.O. 14043. USPTO will also not request the submission of any medical information related to a request for an exception from the vaccination requirement pursuant to E.O. 14043 while the injunction remains in place. But USPTO may nevertheless receive information regarding a medical exception. That is because, if USPTO were to receive a request for an exception from the COVID–19 vaccination requirement pursuant to E.O. 14043 during the pendency of the injunction, USPTO will accept the request, hold it in abeyance, and notify the employee who submitted the request that implementation and enforcement of the COVID–19 vaccination requirement pursuant to E.O. 14043 is currently PO 00000 Frm 00017 Fmt 4703 Sfmt 4703 enjoined and that an exception therefore is not necessary so long as the injunction is in place. In other words, during the pendency of the injunction, any information collection related to requests for medical exception from the COVID–19 vaccination requirement pursuant to E.O. 14043 is not undertaken to implement or enforce the COVID–19 vaccination requirement. II. Method of Collection USPTO utilizes its USPTO Accommodation Point for employees to request accommodations. The individual responder/medical service provider will fill out the required fields of the form and submit the completed form to the appropriate USPTO personnel/employee requesting the accommodation. A link to this form or a PDF version may be emailed to respondents who will then print it out to complete it manually or complete it electronically. USPTO will continue to explore options to use technology to reduce the burden on respondents. III. Data OMB Control Number: 0651–0087. Forms: • USPTO–OEEOD Form 303 (COVID– 19 Vaccine Supplemental Medical Provider Statement) Type of Review: Extension and revision of a currently approved information collection. Affected Public: Private sector. Respondent’s Obligation: Required to obtain or retain benefits. Estimated Number of Annual Respondents: 150 respondents. Estimated Number of Annual Responses: 150 responses. Estimated Time per Response: The USPTO estimates that the responses in this information collection will take the public approximately 10 minutes (0.167 hours) to complete. This includes the time to gather the necessary information, create the document, and submit the completed request to the USPTO. Estimated Total Annual Respondent Burden Hours: 25 hours. Estimated Total Annual Respondent Hourly Cost Burden: $2,557. E:\FR\FM\24MRN1.SGM 24MRN1 16721 Federal Register / Vol. 87, No. 57 / Thursday, March 24, 2022 / Notices TABLE 1—TOTAL BURDEN HOURS AND HOURLY COSTS TO RESPONDENTS Item No. Item 1 ......................... Estimated annual respondents Estimated responses per respondent Estimated annual responses Estimated time for response (hour) Estimated burden (hour/year) Rate ($/hour) Estimated Annual respondent cost burden (a) (b) (a) × (b) = (c) (d) (c) × (d) = (e) (f) (e) × (f) = (g) COVID–19 Vaccine Supplemental Medical Provider Statement. 150 1 150 0.167 (10 minutes). 25 $103.06 $2,577 Totals ....................... 150 ........................ 150 ............................ 25 .................. 2,577 Estimated Total Annual Respondent Non-Hourly Cost Burden: $0. There are no capital start-up, maintenance costs, recordkeeping costs, filing fees, or postage costs associated with this information collection. khammond on DSKJM1Z7X2PROD with NOTICES IV. Request for Comments Kimberly Hardy, Information Collections Officer, Office of the Chief Administrative Officer, United States Patent and Trademark Office. [FR Doc. 2022–06333 Filed 3–23–22; 8:45 am] BILLING CODE 3510–16–P 17:39 Mar 23, 2022 National Nuclear Security Administration Defense Programs Advisory Committee Department of Energy, National Nuclear Security Administration, Office of Defense Programs. ACTION: Notice of closed meeting. AGENCY: The USPTO is soliciting public comments to: (a) Evaluate whether the collection of information is necessary for the proper performance of the functions of the Agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the Agency’s estimate of the burden of the collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; and (d) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. All comments submitted in response to this notice are a matter of public record. USPTO will include or summarize each comment in the request to OMB to approve this information collection. Before including an address, phone number, email address, or other personally identifiable information (PII) in a comment, be aware that the entire comment— including PII—may be made publicly available at any time. While you may ask in your comment to withhold PII from public view, USPTO cannot guarantee that it will be able to do so. VerDate Sep<11>2014 DEPARTMENT OF ENERGY Jkt 256001 This notice announces a closed meeting of the Defense Programs Advisory Committee (DPAC). The Federal Advisory Committee Act requires that public notice of meetings be announced in the Federal Register. Due to national security considerations, the meeting will be closed to the public and matters to be discussed are exempt from public disclosure under an Executive Order, and the Atomic Energy Act of 1954. DATES: April 6, 2022; 1:00 p.m. to 4:00 p.m. ADDRESSES: Microsoft Teams Video Conferencing. FOR FURTHER INFORMATION CONTACT: Ms. Watti Hill, Office of Strategic Partnership Programs (NA–10.1) National Nuclear Security Administration, U.S. Department of Energy, 1000 Independence Ave. SW, Washington, DC 20585, (202) 586–8266; watti.hill@nnsa.doe.gov. SUPPLEMENTARY INFORMATION: Background: The DPAC provides advice and recommendations to the Deputy Administrator for Defense Programs on topics related to Defense Programs mission areas and those of the National Nuclear Security Administration. Purpose of the Meeting: The Quarterly meeting of the Defense Programs Advisory Committee (DPAC) will cover the current status of Committee activities as well as additional charges and is expected to contain discussions of a sensitive nature. Type of Meeting: In the interest of national security, the meeting will be closed to the public. The Federal SUMMARY: PO 00000 Frm 00018 Fmt 4703 Sfmt 4703 Advisory Committee Act, 5 U.S.C. App. 2, section 10(d), and the Federal Advisory Committee Management Regulation, 41 CFR 102–3.155, incorporate by reference the Government in the Sunshine Act, 5 U.S.C. 552b, which, at 552b(c)(1) and (c)(3) permits closure of meetings where restricted data or other classified matters will be discussed. Tentative Agenda: Welcome; Headquarters and DPAC Updates; discussion of reports and current actions; discussion of next charges; conclusion. Public Participation: There will be no public participation in this closed meeting. Those wishing to provide written comments or statements to the Committee are invited to send them to Ms. Watti Hill at the address listed above. Minutes: The minutes of the meeting will not be available. Signed in Washington, DC, on March 15, 2022. LaTanya Butler, Deputy Committee Management Officer. [FR Doc. 2022–05860 Filed 3–23–22; 8:45 am] BILLING CODE 6450–01–P DEPARTMENT OF ENERGY Federal Energy Regulatory Commission [Docket No. ER22–1370–000] Sunlight Storage, LLC; Supplemental Notice That Initial Market-Based Rate Filing Includes Request for Blanket Section 204 Authorization This is a supplemental notice in the above-referenced proceeding of Sunlight Storage, LLC’s application for marketbased rate authority, with an accompanying rate tariff, noting that such application includes a request for blanket authorization, under 18 CFR part 34, of future issuances of securities and assumptions of liability. Any person desiring to intervene or to protest should file with the Federal Energy Regulatory Commission, 888 E:\FR\FM\24MRN1.SGM 24MRN1

Agencies

[Federal Register Volume 87, Number 57 (Thursday, March 24, 2022)]
[Notices]
[Pages 16719-16721]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-06333]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

United States Patent and Trademark Office


Agency Information Collection Activities; Submission to the 
Office of Management and Budget (OMB) for Review and Approval; Comment 
Request; COVID-19 Vaccine Supplemental Medical Provider Statement

AGENCY: United States Patent and Trademark Office, Department of 
Commerce.

ACTION: Notice of information collection; request for comment.

-----------------------------------------------------------------------

[[Page 16720]]

SUMMARY: The United States Patent and Trademark Office (USPTO), as 
required by the Paperwork Reduction Act of 1995, invites comments on 
the extension and revision of an existing information collection: 0651-
0087 (COVID-19 Vaccine Supplemental Medical Provider Statement). The 
purpose of this notice is to allow 60 days for public comment preceding 
submission of the information collection to OMB.

DATES: To ensure consideration, comments regarding this information 
collection must be received on or before May 23, 2022.

ADDRESSES: Interested persons are invited to submit written comments by 
any of the following methods. Do not submit Confidential Business 
Information or otherwise sensitive or protected information.
     Email: [email protected]. Include ``0651-
0087 comment'' in the subject line of the message.
     Federal Rulemaking Portal: http://www.regulations.gov.
     Mail: Kimberly Hardy, Office of the Chief Administrative 
Officer, United States Patent and Trademark Office, P.O. Box 1450, 
Alexandria, VA 22313-1450.

FOR FURTHER INFORMATION CONTACT: Request for additional information 
should be directed to Naveen Paul, Office of Equal Employment 
Opportunity and Diversity, United States Patent and Trademark Office, 
P.O. Box 1450, Alexandria, VA 22313-1450; by telephone at 571-270-5395; 
or by email at [email protected] with ``0651-0087 comment'' in the 
subject line. Additional information about this information collection 
is also available at http://www.reginfo.gov under ``Information 
Collection Review.''

SUPPLEMENTARY INFORMATION:

I. Abstract

    Consistent with guidance from the Centers for Disease Control and 
Prevention (CDC), guidance from the Safer Federal Workforce Task Force 
established pursuant to E.O. 13991 of January 20, 2021, Protecting the 
Federal Workforce and Requiring Mask-Wearing, and E.O. 14043 of 
September 9, 2021, Requiring Coronavirus Disease 2019 Vaccination for 
Federal Employees, the request for this collection of information is 
essential to implement the USPTO health and safety measures regarding 
the Federal employee medical exemptions to the COVID-19 mandatory 
vaccinations. The Rehabilitation Act of 1973, as amended, requires 
Federal agencies to provide reasonable accommodations to qualified 
employees with disabilities unless that reasonable accommodation would 
impose an undue hardship on the employee's agency. See 29 U.S.C. 791; 
29 CFR part 1614; see also 20 CFR part 1630 and E.O.13164 of July 26, 
2000, Requiring Federal Agencies to Establish Procedures to Facilitate 
the Provision of Reasonable Accommodation. Section 2 of E.O. 14043 
mandates that each agency ``implement, to the extent consistent with 
applicable law, a program to require COVID-19 vaccination for all of 
its Federal employees, with exceptions only as required by law.'' This 
COVID-19 Vaccine Supplemental Medical Provider Statement is necessary 
for USPTO to determine legal exemptions to the vaccine requirement 
under the Rehabilitation Act.
    The vaccination requirement issued pursuant to E.O. 14043, is 
currently the subject of a nationwide injunction. While that injunction 
remains in place, USPTO will not process requests for a medical 
exception from the COVID-19 vaccination requirement pursuant to E.O. 
14043. USPTO will also not request the submission of any medical 
information related to a request for an exception from the vaccination 
requirement pursuant to E.O. 14043 while the injunction remains in 
place. But USPTO may nevertheless receive information regarding a 
medical exception. That is because, if USPTO were to receive a request 
for an exception from the COVID-19 vaccination requirement pursuant to 
E.O. 14043 during the pendency of the injunction, USPTO will accept the 
request, hold it in abeyance, and notify the employee who submitted the 
request that implementation and enforcement of the COVID-19 vaccination 
requirement pursuant to E.O. 14043 is currently enjoined and that an 
exception therefore is not necessary so long as the injunction is in 
place. In other words, during the pendency of the injunction, any 
information collection related to requests for medical exception from 
the COVID-19 vaccination requirement pursuant to E.O. 14043 is not 
undertaken to implement or enforce the COVID-19 vaccination 
requirement.

II. Method of Collection

    USPTO utilizes its USPTO Accommodation Point for employees to 
request accommodations. The individual responder/medical service 
provider will fill out the required fields of the form and submit the 
completed form to the appropriate USPTO personnel/employee requesting 
the accommodation. A link to this form or a PDF version may be emailed 
to respondents who will then print it out to complete it manually or 
complete it electronically. USPTO will continue to explore options to 
use technology to reduce the burden on respondents.

III. Data

    OMB Control Number: 0651-0087.
    Forms:
     USPTO-OEEOD Form 303 (COVID-19 Vaccine Supplemental 
Medical Provider Statement)
    Type of Review: Extension and revision of a currently approved 
information collection.
    Affected Public: Private sector.
    Respondent's Obligation: Required to obtain or retain benefits.
    Estimated Number of Annual Respondents: 150 respondents.
    Estimated Number of Annual Responses: 150 responses.
    Estimated Time per Response: The USPTO estimates that the responses 
in this information collection will take the public approximately 10 
minutes (0.167 hours) to complete. This includes the time to gather the 
necessary information, create the document, and submit the completed 
request to the USPTO.
    Estimated Total Annual Respondent Burden Hours: 25 hours.
    Estimated Total Annual Respondent Hourly Cost Burden: $2,557.

[[Page 16721]]



                                               Table 1--Total Burden Hours and Hourly Costs to Respondents
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                                             Estimated
                                            Estimated       Estimated       Estimated     Estimated time for     Estimated     Rate ($/       Annual
      Item No.               Item            annual       responses per      annual        response (hour)     burden (hour/     hour)      respondent
                                           respondents     respondent       responses                              year)                    cost burden
                                                    (a)             (b)     (a) x (b) =  (d)................     (c) x (d) =         (f)     (e) x (f) =
                                                                                    (c)                                  (e)                         (g)
--------------------------------------------------------------------------------------------------------------------------------------------------------
1...................  COVID-19 Vaccine              150               1             150  0.167 (10 minutes).              25     $103.06          $2,577
                       Supplemental
                       Medical Provider
                       Statement.
                                        ----------------------------------------------------------------------------------------------------------------
                         Totals........             150  ..............             150  ...................              25  ..........           2,577
--------------------------------------------------------------------------------------------------------------------------------------------------------

    Estimated Total Annual Respondent Non-Hourly Cost Burden: $0. There 
are no capital start-up, maintenance costs, recordkeeping costs, filing 
fees, or postage costs associated with this information collection.

IV. Request for Comments

    The USPTO is soliciting public comments to:
    (a) Evaluate whether the collection of information is necessary for 
the proper performance of the functions of the Agency, including 
whether the information will have practical utility;
    (b) Evaluate the accuracy of the Agency's estimate of the burden of 
the collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected; and
    (d) Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.
    All comments submitted in response to this notice are a matter of 
public record. USPTO will include or summarize each comment in the 
request to OMB to approve this information collection. Before including 
an address, phone number, email address, or other personally 
identifiable information (PII) in a comment, be aware that the entire 
comment-- including PII--may be made publicly available at any time. 
While you may ask in your comment to withhold PII from public view, 
USPTO cannot guarantee that it will be able to do so.

Kimberly Hardy,
Information Collections Officer, Office of the Chief Administrative 
Officer, United States Patent and Trademark Office.
[FR Doc. 2022-06333 Filed 3-23-22; 8:45 am]
BILLING CODE 3510-16-P